Advisors Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Advisors Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,848	Closed	-$160K	–	1556
2020 Q3	$160K	Sell	3,848 -4,983	-56%	-$229K	﹤0.01%	1228
2020 Q2	$423K	Sell	8,831 -92	-1%	-$7.11K	0.01%	947
2020 Q1	$562K	Sell	8,923 -383	-4%	-$34.4K	0.01%	788
2019 Q4	$1.15M	Sell	9,306 -6,493	-41%	-$581K	0.02%	708
2019 Q3	$1.05M	Sell	15,799 -441	-3%	-$29.6K	0.02%	743
2019 Q2	$1.29M	Sell	16,240 -413	-2%	-$37K	0.02%	698
2019 Q1	$1.86M	Buy	16,653 +2,410	+17%	+$263K	0.03%	583
2018 Q4	$1.44M	Buy	14,243 +7,547	+113%	+$782K	0.03%	638
2018 Q3	$846K	Buy	+6,696	New	+$709K	0.01%	892
2017 Q1	–	Sell	-516	Closed	-$56K	–	1784
2016 Q4	$56K	Sell	516 -75	-13%	-$8.94K	﹤0.01%	1673
2016 Q3	$97K	Sell	591 -6	-1%	-$946	﹤0.01%	1524
2016 Q2	$85K	Sell	597 -26	-4%	-$3.79K	﹤0.01%	1550
2016 Q1	$80K	Buy	623 +15	+2%	+$1.77K	﹤0.01%	1514
2015 Q4	$91K	Sell	608 -1,873	-75%	-$317K	﹤0.01%	1579
2015 Q3	$411K	Buy	2,481 +1,672	+207%	+$368K	0.01%	1141
2015 Q2	$195K	Sell	809 -66	-8%	-$17.6K	﹤0.01%	1381
2015 Q1	$247K	Sell	875 -8	-0.9%	-$1.73K	﹤0.01%	1286
2014 Q4	$138K	Buy	883 +18	+2%	+$3.33K	﹤0.01%	1403
2014 Q3	$205K	Buy	865 +91	+12%	+$23.2K	﹤0.01%	1289
2014 Q2	$183K	Buy	774 +650	+524%	+$171K	﹤0.01%	1302
2014 Q1	$41K	Buy	+124	New	+$41.8K	﹤0.01%	1676

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Advisors Asset Management's ICPT Position: Q4 2020 in Review

Advisors Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2020, closing a stake of 3,848 shares — an estimated $160K sold.

Advisors Asset Management first reported a position in ICPT in Q1 2014 and held it in 21 quarters. The position peaked at $1.86M in Q1 2019. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

Advisors Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Advisors Asset Management sold 3,848 Intercept Pharmaceuticals, Inc. shares in Q4 2020, an estimated $160K.
Advisors Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 21 quarters.
Advisors Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $1.86M in Q1 2019.
175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on Advisors Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.